feed,title,long_url,short_url
Benzinga,Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance,https://www.benzinga.com/pressreleases/20/11/g18357527/meridian-bioscience-reports-strong-fourth-quarter-and-record-full-year-fiscal-2020-operating-resul,https://j.mp/2UlQYjB
Benzinga,Knight Therapeutics Reports Third Quarter 2020 Results,https://www.benzinga.com/pressreleases/20/11/g18357522/knight-therapeutics-reports-third-quarter-2020-results,https://j.mp/36vh09H
Benzinga,Plus Therapeutics Announces Webinar to Present ReSPECTâ„¢ Glioblastoma Clinical Trial Update,https://www.benzinga.com/pressreleases/20/11/g18357514/plus-therapeutics-announces-webinar-to-present-respect-glioblastoma-clinical-trial-update,https://j.mp/36uGSTb
Benzinga,Crinetics Hosting Key Opinion Leader Meeting Focusing on Oral Paltusotine for the Treatment of Acromegaly,https://www.benzinga.com/pressreleases/20/11/g18357512/crinetics-hosting-key-opinion-leader-meeting-focusing-on-oral-paltusotine-for-the-treatment-of-acr,https://j.mp/3kxo4aB
Benzinga,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18357510/fulcrum-therapeutics-to-participate-in-upcoming-investor-conferences,https://j.mp/36DL7fk
